Cephalexin: Effective Bacterial Infection Treatment
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.40 | $42.15 (0%) | 🛒 Add to cart |
| 60 | $1.09 | $84.30 $65.23 (23%) | 🛒 Add to cart |
| 90 | $0.97 | $126.45 $87.31 (31%) | 🛒 Add to cart |
| 120 | $0.92 | $168.60 $110.39 (35%) | 🛒 Add to cart |
| 180 | $0.85 | $252.90 $153.55 (39%) | 🛒 Add to cart |
| 270 | $0.83 | $379.35 $222.79 (41%) | 🛒 Add to cart |
| 360 | $0.81
Best per pill | $505.80 $290.03 (43%) | 🛒 Add to cart |
Cephalexin is a first-generation cephalosporin antibiotic prescribed to combat a wide range of bacterial infections. It operates by inhibiting bacterial cell wall synthesis, leading to the eradication of susceptible organisms. This medication is a cornerstone in outpatient treatment due to its reliable efficacy, broad spectrum of activity, and generally favorable safety profile. Healthcare providers frequently rely on cephalexin for its predictable pharmacokinetics and well-documented clinical success in treating common community-acquired infections.
Features
- Active Ingredient: Cephalexin monohydrate
- Drug Class: First-generation cephalosporin antibiotic
- Administration: Oral capsules, tablets, and oral suspension
- Mechanism of Action: Inhibits bacterial cell wall synthesis
- Spectrum: Effective against many Gram-positive and some Gram-negative bacteria
- Bioavailability: Well-absorbed from the gastrointestinal tract
- Half-life: Approximately 0.5–1.2 hours in adults with normal renal function
Benefits
- Rapidly achieves bactericidal concentrations at the site of infection
- Effective against common pathogens causing skin, respiratory, and urinary tract infections
- Generally well-tolerated with a low incidence of severe adverse effects
- Suitable for both adult and pediatric populations (in appropriate formulations)
- Can be taken with or without food, enhancing patient compliance
- Available as a generic medication, making it cost-effective
Common use
Cephalexin is indicated for the treatment of infections caused by susceptible strains of microorganisms. Common clinical applications include skin and soft tissue infections such as cellulitis and impetigo, respiratory tract infections including streptococcal pharyngitis and community-acquired pneumonia (for penicillin-allergic patients), bone infections, genitourinary tract infections including acute prostatitis and uncomplicated cystitis, and otitis media. Its utility extends to surgical prophylaxis in certain procedures, particularly those involving the skin. The decision to use cephalexin should be based on culture and susceptibility testing whenever possible, though empirical therapy is often initiated based on local antibiogram data.
Dosage and direction
Dosage must be individualized based on the infection’s severity, the patient’s renal function, and the susceptibility of the causative organisms. For most adults, the usual dose is 250 mg every 6 hours or 500 mg every 12 hours. For more severe infections, doses may be increased to 500 mg every 6 hours or 1 g every 12 hours. The total daily dose should not exceed 4 grams.
For pediatric patients, the recommended dosage is 25–50 mg/kg/day in divided doses. For otitis media, doses of 75–100 mg/kg/day in divided doses may be used, not to exceed 4 grams daily.
Cephalexin is best absorbed when administered on an empty stomach but can be taken with food to minimize gastrointestinal upset. The oral suspension should be shaken well before each use. Patients should complete the entire course of therapy, even if symptoms improve before the medication is finished, to prevent the development of antibiotic resistance.
Precautions
Before initiating cephalexin therapy, a careful patient history should be obtained, with particular attention to previous hypersensitivity reactions to cephalosporins, penicillins, or other drugs. Use with caution in patients with a history of gastrointestinal disease, particularly colitis. Renal function should be assessed, especially in elderly patients or those with pre-existing renal impairment, as dosage adjustments may be necessary.
Prolonged use may result in the overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs during therapy, appropriate measures should be taken. Cephalexin should be prescribed with caution in patients with a history of seizure disorders, as neurotoxicity (including seizures) has been reported with cephalosporins, especially in patients with renal impairment.
Contraindications
Cephalexin is contraindicated in patients with known hypersensitivity to cephalexin or any component of the formulation. It is also contraindicated in patients who have experienced anaphylactic reactions to penicillins or other cephalosporins due to the potential for cross-reactivity. The medication should not be used for the treatment of viral infections, as antibiotics are ineffective against viruses.
Possible side effect
The most commonly reported adverse reactions involve the gastrointestinal system and include diarrhea (occurring in up to 10% of patients), nausea, vomiting, abdominal pain, and dyspepsia. Other reported side effects include dizziness, fatigue, headache, and genital pruritus. Allergic reactions may manifest as skin rash, urticaria, angioedema, and, rarely, anaphylaxis.
Transient abnormalities in laboratory findings may occur, including elevated hepatic enzymes, eosinophilia, and neutropenia. Pseudomembranous colitis has been reported with nearly all antibacterial agents, including cephalexin, and may range in severity from mild to life-threatening.
Drug interaction
Probenecid may decrease the renal tubular secretion of cephalexin, resulting in increased and prolonged blood levels. Concomitant use of cephalexin with potent diuretics may increase the risk of nephrotoxicity. The administration of cephalexin may result in a false-positive reaction for glucose in the urine when using Benedict’s solution, Fehling’s solution, or Clinitest tablets.
Cephalexin may potentially enhance the effect of warfarin and other oral anticoagulants, necessitating closer monitoring of coagulation parameters. The absorption of cephalexin may be reduced when taken with multivalent cation-containing products (such as antacids or iron preparations); administering these agents at least 2 hours apart is recommended.
Missed dose
If a dose is missed, it should be taken as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one, as this may increase the risk of adverse effects.
Overdose
Symptoms of cephalexin overdose may include nausea, vomiting, epigastric distress, diarrhea, and hematuria. In the event of overdose, general supportive measures should be instituted. Gastric lavage may be indicated if performed soon after ingestion. Cephalexin is eliminated primarily by the kidneys, so forced diuresis, peritoneal dialysis, hemodialysis, or charcoal hemoperfusion may be considered in severe cases, though the efficacy of these interventions is not well-established.
Storage
Cephalexin capsules and tablets should be stored at controlled room temperature (20°–25°C or 68°–77°F) in a tight, light-resistant container. The oral suspension, once reconstituted, should be stored in the refrigerator (2°–8°C or 36°–46°F) and discarded after 14 days. All medications should be kept out of reach of children and pets.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. The content provided is not a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read here. The manufacturer’s prescribing information should be consulted for complete details.
Reviews
Clinical studies and post-marketing surveillance demonstrate cephalexin’s consistent efficacy in treating susceptible infections, with success rates typically exceeding 85% for indicated conditions. Patient satisfaction surveys indicate generally good tolerability, though gastrointestinal side effects are noted by some users. Healthcare professionals appreciate its predictable pharmacokinetics and favorable safety profile, making it a first-line choice for many common bacterial infections. Long-term clinical experience spanning decades supports its position as a reliable antibiotic option in appropriate clinical scenarios.